Ottoflox (Ofloxacin)

Ofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes that are essential for DNA replication and transcription. This inhibition stops bacterial cells from multiplying, leading to a bactericidal effect against susceptible organisms.

The dosage of Ottoflox is set by the prescribing clinician based on the type and severity of the infection, patient age, weight, kidney function and other clinical factors. Patients should follow the prescriber’s instructions and the product label.

Ofloxacin is classified as pregnancy‑category C in many regions, meaning it should only be used when the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk, so breastfeeding mothers should use it only if clearly needed and after consulting a healthcare professional.

To order Ottoflox, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ottoflox (Ofloxacin) shares the class‑wide mechanism of DNA‑gyrase inhibition with other fluoroquinolones such as ciprofloxacin and levofloxacin. Compared with some alternatives, Ofloxacin offers a broad spectrum against Gram‑negative organisms and good oral bioavailability, but individual drug choice depends on local resistance patterns and patient‑specific factors.

Ottoflox tablets should be stored at temperatures below 25 °C, in the original container, protected from moisture and direct light. This helps maintain potency throughout the product’s shelf‑life.

Ottoflox is supplied as oral tablets that are taken with a full glass of water. It may be taken with or without food, but patients should avoid concurrent intake of antacids or mineral supplements that could interfere with absorption.

Serious adverse reactions to Ofloxacin include tendon rupture or inflammation, peripheral neuropathy, severe skin reactions such as Stevens‑Johnson syndrome, QT‑interval prolongation and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience any of these events.

Ottoflox should be avoided in individuals with a known hypersensitivity to fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and patients taking medications that have major interactions unless closely monitored. It is also contraindicated in pregnancy unless clearly indicated.